SAVIMS

SAVIMS logo white
Menu

Vaccines

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccines, Viral illnesses

Understanding RRR and ARR in Vaccine Trials

| | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccines, Viral illnesses

Reference: Iriarte, I., & Phoenix, S. (2021). Understanding relative risk reduction (RRR) and absolute risk reduction (ARR) in vaccine trials. PANDA. https://www.pandata.org/understanding-relative-risk-reduction-and-absolute-risk-reduction-in-vaccine-trials/ Summary: The article discusses the critical distinctions between Relative Risk Reduction (RRR) and Absolute Risk Reduction (ARR) in the context of vaccine trials, particularly those for COVID-19. RRR compares the efficacy of one […]

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Detection of Graphene in COVID-19 Vaccines

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Campra, P. (2021). Detection of graphene in COVID-19 vaccines by micro-Raman spectroscopy. Technical Report. Almeria, Spain: Universidad de Almería. Summary: This technical report by Professor Pablo Campra investigates the presence of graphene in various COVID-19 vaccine samples using a technique called micro-Raman spectroscopy. The study screened seven vials from four different vaccine brands, identifying

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Peer-reviewed evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Efficacy and Safety of BNT162b2 mRNA Covid-19 Vaccine at 6 Months

| | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Peer-reviewed evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Thomas, S. J., Moreira, E. D. Jr., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., … & Jansen, K. U. (2021). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. The New England Journal of Medicine, 385(19), 1761-1773. https://doi.org/10.1056/NEJMoa2110345 Summary: The BNT162b2 mRNA vaccine demonstrates high efficacy and safety against Covid-19,

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Safety and Efficacy of BNT162b2 mRNA Covid-19 Vaccine through 6 Months

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Thomas, S. J., Moreira, E. D. Jr., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., … & Jansen, K. U. (2021). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. New England Journal of Medicine, 385(19), 1761-1773. https://doi.org/10.1056/NEJMoa2110345 Summary: The article investigates the safety and efficacy of the BNT162b2 mRNA Covid-19

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Updated COVID-19 Adverse Events Following Immunisation

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: CEPI. (2022, October). COVID-19 AESI including status of associated Brighton case definitions. Retrieved from [insert URL here] Summary: The document presents an updated list of Adverse Events Following Immunisation (AESI) related to COVID-19, alongside their Brighton case definitions. It categorises various conditions such as acute respiratory distress syndrome, myocarditis, and thrombosis, indicating their publication

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19 Associated Events of Special Interest: A Comprehensive Overview

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: CEPI. (2021). COVID-19 associated events of special interest including status of associated Brighton case definitions. Retrieved from https://docs.google.com/spreadsheets/d/1QgF35nYcsaFN3DZTOtV_lP0TYqQzsDMUQBAd5M9brrM/edit#gid=1666959512 Summary: This document provides an overview of COVID-19 associated events of special interest (AESI) alongside their Brighton case definitions as of October 2021. It categorises AESIs into three groups: those seen with COVID-19 disease, those with

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Concerns Over COVID-19 Vaccination for Children Aged 5-11

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Kennedy, R. F., & Nass, M. (2021). Concerns over COVID-19 vaccination for children aged 5-11. Retrieved from Children’s Health Defense. Summary: In a letter to the FDA and VRBPAC members, Children’s Health Defense (CHD) expressed strong opposition to the potential Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine for children aged 5-11. The

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Majority of COVID-19 Deaths in Sweden and UK Among Fully Vaccinated

| | COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Wolfe, R. (2021, October 21). Fully vaccinated were the majority of COVID deaths in Sweden, UK in September. LifeSite. https://www.lifesitenews.com/news/fully-vaccinated-people-now-the-majority-of-covid-deaths-in-uk-sweden/ Summary: Recent data from Sweden and the UK reveals that “fully vaccinated” individuals comprised the majority of COVID-19 deaths in September 2021. In Sweden, 70% of COVID fatalities between September 1-24 were among fully

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Summary of Public Health Scotland’s COVID-19 Statistical Report (Public Health Scotland – 2021)

| | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Public Health Scotland. (2021). COVID-19 statistical report: As at 18 October 2021. Retrieved from https://www.publichealthscotland.scot/ Summary: The Public Health Scotland COVID-19 Statistical Report, published on 20 October 2021, provides a comprehensive overview of COVID-19 incidence and related data in Scotland. As of 17 October 2021, there were 609,959 confirmed cases, with a notable decrease

Scroll to Top